2025-08-08 - Analysis Report
Okay, here's an analysis of Merck & Co Inc (MRK) based on the data you provided. I'll format it as a concise report in English, starting with key numbers and then adding analysis.

## Merck & Co Inc (MRK) Stock Analysis

**Ticker:** MRK
**Company Description:** Merck & Co Inc is a global pharmaceutical company that develops and manufactures a wide range of healthcare products.

### 1. Performance vs. S&P 500 (VOO)

*   **MRK Cumulative Return:** -9.59%
*   **VOO Cumulative Return:** 82.59%
*   **Absolute Divergence:** -104.1
*   **Relative Divergence:** 3.4 (Indicates MRK's performance is near the bottom range of its historical divergence from VOO).

**Analysis:** MRK has significantly underperformed the S&P 500 over the period examined. The large negative divergence suggests substantial underperformance relative to the broader market.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| :----------- | :----- | :----- | :------ | :----- | :----- |
| 2015-2017  | 2.0%  | 0.0%   | 0.0%   | 0.9   | 134.1  |
| 2016-2018  | 33.0%  | 66.4%  | 38.0%   | 0.2   | 182.1  |
| 2017-2019  | 53.0%  | 66.4%  | 30.0%   | 0.2   | 216.8  |
| 2018-2020  | 19.0%  | 66.4%  | -8.0%  | 0.1   | 195.0  |
| 2019-2021  | -2.0%  | 65.6%  | -51.0%  | 0.0   | 191.4  |
| 2020-2022  | 13.0%  | 69.4%  | 6.0%   | 0.0   | 277.1  |
| 2021-2023  | 31.0%  | 69.4%  | 11.0%   | 0.2   | 272.3  |
| 2022-2024  | -7.0%  | 69.4%  | -34.0%  | 0.2   | 248.5  |
| 2023-2025  | -63.0% | 71.5% | -110.0% | 0.4  | 200.8 |

**Analysis:**

*   **Alpha:**  MRK's alpha has been volatile, with significant negative values in recent periods (2018-2020, 2019-2021, 2022-2024, and 2023-2025), indicating underperformance relative to its expected return based on market movements.  The most recent period shows a particularly large negative alpha.
*   **Beta:** Beta values are generally low (close to 0), suggesting that MRK's price movements have been less sensitive to overall market movements than the S&P 500 (VOO).
*   **CAGR and MDD:** MRK's CAGR has varied significantly across different periods. The MDD (Maximum Drawdown) figures are quite high, indicating significant potential losses over the specified timeframes. The most recent MDD is the highest.
*   **Cap(B):** Market capitalization has fluctuated over time, reflecting changes in the company's valuation.

### 2. Recent Stock Price Movements

*   **Current Price:** 80.37
*   **Previous Close:** 79.44
*   **Change:** 1.17 (a positive change)
*   **5-Day Moving Average:** 79.95
*   **20-Day Moving Average:** 81.6245
*   **60-Day Moving Average:** 79.8877

**Analysis:** The current price is above the 5-day and 60-day moving averages but below the 20-day moving average.  This suggests a possible short-term upward trend, but further observation is needed to confirm.  The recent positive change of 1.17 indicates a small, positive price movement.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3318 (Low Risk)
*   **RSI:** 51.1654
*   **PPO:** -0.4537
*   **Hybrid Signal:** cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.33)
*   **Recent (20-Day) Relative Divergence Change:** 3.4 (Positive - short-term increase)
*   **Expected Return (%):** -299.0 (Significant negative expected return compared to S&P 500)

**Analysis:**

*   The MRI suggests a "Low Risk" environment for MRK.
*   The RSI of 51.1654 is neutral, indicating neither overbought nor oversold conditions.
*   The PPO is negative, which might suggest a slightly bearish trend.
*   The Hybrid Signal is advising caution and suggests reducing holdings slightly, indicating a potential need to reduce risk exposure.
*   The recent positive change in relative divergence indicates a short-term improvement in MRK's performance compared to the S&P 500.
*   The extremely negative expected return warrants careful consideration. This suggests models predict significant underperformance over the long term compared to the S&P 500, and could be related to one-time-costs.

### 4. Recent News & Significant Events

*   **2025-08-07:**  Major business developments, regulatory changes, or market events.
*   **2025-08-06:** Analyst discussions on performance, industry trends, and global economic factors.
*   **2025-08-08:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-05:** Market experts highlight both risks and opportunities, advising monitoring of news and announcements.

**Analysis:**  Recent news suggests increased volatility and significant events impacting MRK. Investors should monitor news and company announcements closely to understand the drivers behind these events.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
| :--------- | :--- | :---------- |
| 2025-08-05 | 1.76 | 15.81 B$    |
| 2025-05-02 | 2.01 | 15.53 B$    |
| 2024-11-06 | 1.25 | 16.66 B$    |
| 2024-08-05 | 2.15 | 16.11 B$    |
| 2025-08-05 | 2.15 | 16.11 B$    |

**Analysis:**  The provided EPS and revenue figures show some variability. EPS decreased substantially in the most recent quarter, suggesting either increased costs or reduced profitability, and the decrease in revenue may have played a role.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue      | Profit Margin |
| :----------- | :----------- | :------------ |
| 2025-06-30 | $15.81B    | 77.50%        |
| 2025-03-31 | $15.53B    | 77.98%        |
| 2024-12-31 | $15.62B    | 75.50%        |
| 2024-09-30 | $16.66B    | 75.51%        |
| 2024-06-30 | $16.11B    | 76.76%        |

**Capital and Profitability:**

| Quarter      | Equity       | ROE   |
| :----------- | :----------- | :---- |
| 2025-06-30 | $48.99B    | 9.04% |
| 2025-03-31 | $48.34B    | 10.51% |
| 2024-12-31 | $46.31B    | 8.08% |
| 2024-09-30 | $44.50B    | 7.09% |
| 2024-06-30 | $43.58B    | 12.52% |

**Analysis:**

*   **Revenue and Profit Margin:** While revenue has fluctuated, the profit margins have remained relatively stable and high, indicating strong operational efficiency. However, revenue has decreased slightly in the most recent quarter.
*   **Equity and ROE:** Equity has generally increased over the periods, suggesting asset growth. ROE (Return on Equity) has fluctuated, but with a lower number in the latest quarter, indicating decreased efficiency in generating profit from equity.

### 7. Overall Summary

Based on the provided data, MRK is currently underperforming the broader market (S&P 500). Recent news suggests volatility and significant events are impacting the stock. The low MRI suggests the stock is a relatively low risk, although the hybrid signal indicates it might be wise to reduce holdings. While revenue has remained strong and profit margins are high, the recent EPS decline and the very large negative expected return are causes for concern.

**Key Takeaways:**

*   **Underperformance:** Significant underperformance compared to the S&P 500.
*   **Volatility:** Recent news indicates potential volatility.
*   **Financial Health:** Strong revenue and profit margins, but declining EPS and ROE in recent quarters need monitoring.
*   **Future Outlook:** The extremely negative expected return warrants careful evaluation and further investigation.
*   **Recommendation:** Given the mixed signals, a cautious approach is warranted. Monitor news, company announcements, and financial performance closely. The large negative expected return suggests avoiding investment at this time, or performing significant additional due diligence.
